A chymase gene variant is associated with atherosclerosis in venous coronary artery bypass grafts

Coronary Artery Disease

Volumn 12, Issue 6, 2001, Pages 493-497

  Ortlepp, Jan R ^a   Janssens, Uwe ^a   Bleckmann, Frank ^a   Lauscher, Johannes ^a   Merkelbach Bruse, Sabine ^a   Hanrath, Peter ^a   Hoffmann, Rainer ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Atherosclerosis; Coronary artery bypass graft; Heart chymase; Polymorphism; Renin angiotensin aldosterone system

Indexed keywords

ALDOSTERONE SYNTHASE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; CHYMASE; CYTOCHROME P450; DIPEPTIDYL CARBOXYPEPTIDASE; GENE PRODUCT; RECEPTOR SUBTYPE;

ADULT; AGED; ALLELISM; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CORONARY ARTERY BYPASS GRAFT; CORRELATION FUNCTION; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SCORING SYSTEM;

AGED; ANALYSIS OF VARIANCE; CHYMASES; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; CORONARY VESSELS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEART CATHETERIZATION; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RENIN-ANGIOTENSIN SYSTEM; SERINE ENDOPEPTIDASES;

EID: 0034758259     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200109000-00008     Document Type: Article

References (31)

1. The cardiac renin - Angiotensin system: An appraisal of present experimental and clinical evidence
2. Molecular biology of the renin angiotensin system
3. The renin - Angiotensin - Aldosterone system: A specific target for hypertension
4. Vascular renin - Angiotensin-system, endothelium function and atherosclerosis?
5. Evidence that macrophages in atherosclerotic lesions contain angiotensin II
6. Chronic angiotensin II infusion promotes atherogenesis in low density lipoprotein receptor -/- mice
7. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels
8. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction
9. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease
10. ACE gene polymorphism: Ischemic heart disease and longevity in 10, 150 individuals. A case-referent and retrospective cohort study based on the Copenhagen City Heart Study
11. Vasoconstriction by in situ formed Ang II: Role of ACE and chymase
12. Chymase dependent Ang II formation in vascular tissue
13. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart
14. Increased chymase activity in internal thoracic artery of patients with hypercholesterolemia
15. Increased chymase-dependent Ang II formation in human atherosclerotic aorta
16. Association between myocardial infarction and the mast cells in the adventitia of the infarct related coronary artery
17. Relative localization of angiotensin-converting enzyme, chymase and Ang II in human coronary atherosclerotic lesions
18. Alternative pathways of Ang II production in the human saphenous vein
19. Mast cells are augmented in deep vein thrombosis and express a profibrinolytic phenotype
20. A more meaningful scoring system for determin9 the severity of coronary heart disease
21. Predictive factors of restenosis after coronary stent placement
22. Chymase gene locus is not associated with myocardial infarction and is not linked to heart size or blood pressure
23. Angiotensin-converting enzyme and heart chymase gene polymorphisms in hypertrophic cardiomyopathy
24. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy
25. Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass response to physical training
26. Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function
27. Role of candidate modifier genes on the phenotypic expression of hypertrophy in patients with hypertrophic cardiomyopathy
28. Angiotensin II type 1 receptor gene polymorphisms in patients with cardiac hypertrophy
29. AT1 receptor A/C1166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy
30. Lack of association between a polymorphism of the aldosterone synthase gene and left ventricular structure
31. Absence of association or genetic linkage between the angiotensin-converting enzyme gene and left ventricular mass